We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+24.19%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$136M
AUM Growth
+$21.9M
Cap. Flow
-$8.36M
Cap. Flow %
-6.13%
Top 10 Hldgs %
68.06%
Holding
58
New
8
Increased
12
Reduced
7
Closed
22

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$1.34M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.29M
3
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$943K
4
KIN
Kindred Biosciences, Inc.
KIN
+$596K
5
DGX icon
Quest Diagnostics
DGX
+$593K

Top Sells

Rank Stock Value
1
GIVN
GIVEN IMAGING LTD
GIVN
+$2.57M
2
HUM icon
Humana
HUM
+$1.87M
3
SLTM
SOLTA MED INC (DE)
SLTM
+$1.85M
4
AGN
Allergan plc
AGN
+$1.8M
5
ELV icon
Elevance Health
ELV
+$1.25M

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.3%
2 Healthcare 38.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDY icon
1
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$17.1M 12.54%
70,000
+45,000
+180% +$10.6M
IBB icon
2
PUT
iShares Biotechnology ETF
IBB
$10.8B
$17M 12.5%
+225,000
New +$16M
ANIP icon
3
ANI Pharmaceuticals
ANIP
$1.69B
$9.75M 7.15%
485,410
-68,678
-12% -$890K
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$9.23M 6.78%
50,000
+25,000
+100% +$4.42M
TEVA icon
5
CALL
Teva Pharmaceuticals
TEVA
$43.8B
$8.02M 5.88%
200,000
+100,000
+100% +$3.94M
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.57B
$7.92M 5.81%
1,050,745
+185,000
+21% +$1.29M
AUXL
7
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$6.93M 5.09%
334,481
+50,000
+18% +$943K
PFE icon
8
CALL
Pfizer
PFE
$160B
$6.13M 4.5%
+210,800
New +$6.14M
IWM icon
9
PUT
iShares Russell 2000 ETF
IWM
$81.9B
$5.77M 4.23%
50,000
-25,000
-33% -$2.76M
AZN icon
10
AstraZeneca
AZN
$255B
$4.88M 3.58%
82,239
– –
FRX
11
DELISTED
FOREST LABORATORIES INC
FRX
$4.22M 3.1%
70,382
– –
DGX icon
12
Quest Diagnostics
DGX
$27B
$4.13M 3.03%
77,208
+10,000
+15% +$593K
MRK icon
13
Merck
MRK
$369B
$3.85M 2.83%
80,696
+10,480
+15% +$479K
ENDP
14
PUT
DELISTED
Endo International plc
ENDP
$3.37M 2.48%
50,000
-100,000
-67% -$5.71M
GIVN
15
CALL
DELISTED
GIVEN IMAGING LTD
GIVN
$3.01M 2.21%
+100,000
New +$2.34M
HNT
16
DELISTED
HEALTH NET INC
HNT
$2.97M 2.18%
100,000
– –
QLTI
17
DELISTED
QLT Inc
QLTI
$2.93M 2.15%
526,639
+111,500
+27% +$553K
GSK icon
18
GSK
GSK
$101B
$2.45M 1.8%
36,773
– –
TEVA icon
19
Teva Pharmaceuticals
TEVA
$43.8B
$2.2M 1.62%
55,000
+5,000
+10% +$197K
SNY icon
20
Sanofi
SNY
$107B
$1.76M 1.29%
32,735
– –
SGNT
21
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.49M 1.09%
58,722
-15,100
-20% -$341K
HNT
22
CALL
DELISTED
HEALTH NET INC
HNT
$1.48M 1.09%
50,000
– –
BAX icon
23
Baxter International
BAX
$13.4B
$1.39M 1.02%
+36,820
New +$1.34M
TWM icon
24
CALL
ProShares UltraShort Russell2000
TWM
$44M
$1.2M 0.88%
+1,250
New +$1.34M
AORT icon
25
CALL
Artivion
AORT
$1.3B
$1.11M 0.81%
100,000
+60,100
+151% +$566K
1
2 3

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Healthcare Value Capital held 58 positions worth $136M, up 19% from $114M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Healthcare Value Capital withdrew a net $8.36M in Q4 2013, closing 22 positions and reducing 7 holdings. Its most notable exit was GIVEN IMAGING LTD, an estimated $2.57M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 57% a quarter earlier, followed by Healthcare.

Against the trend, Healthcare Value Capital opened a new position in Baxter International worth $1.39M.

  • Healthcare Value Capital's largest Q4 2013 buy was Baxter International: 36,820 shares worth $1.39M.
  • Healthcare Value Capital added most to Supernus Pharmaceuticals in Q4 2013, an estimated $1.29M increase.
  • Healthcare Value Capital's biggest Q4 2013 reduction was ANI Pharmaceuticals, cutting an estimated $890K.
  • Healthcare Value Capital fully exited GIVEN IMAGING LTD in Q4 2013, selling an estimated $2.57M.
  • Healthcare Value Capital's ten largest holdings make up 68% of its $136M portfolio in Q4 2013.
  • Healthcare Value Capital opened 8 new positions and closed 22 in Q4 2013.
  • Healthcare Value Capital's portfolio value rose 19% quarter-over-quarter to $136M.

Based on Healthcare Value Capital's 13F filing for Q4 2013, filed 13 Feb 2014.